Paper41378487
Glucagon-Like Peptide-1 Receptor Agonists Versus Bariatric Surgery in Patients With Obesity and Heart Failure With Preserved Ejection Fraction.
Ibrahim R and 14 others. J Am Heart Assoc, 2025. Cited by 1 paper, by iCite.
Cite this record
ConductScience Library. Glucagon-Like Peptide-1 Receptor Agonists Versus Bariatric Surgery in Patients With Obesity and Heart Failure With Preserved Ejection Fraction. Papers, record 41378487. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41378487
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Glucagon-Like Peptide-1 Receptor Agonists Versus Bariatric Surgery in Patients With Obesity and Heart Failure With Preserved Ejection Fraction.
- PubMed
Topics13
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Heart Failure | Major topic |
| Bariatric Surgery | Major topic |
| Glucagon-Like Peptide-1 Receptor Agonists | Major topic |
| Obesity | Major topic |
| Stroke Volume | Major topic |
| Humans | |
| Male | |
| Female | |
| Retrospective Studies | |
| Aged | |
| Middle Aged | |
| Treatment Outcome | |
| Incretins |
Source PubMed
References25
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 26808323 | Complications of bariatric surgery: Presentation and emergency management. | Int J Surg | 2016 | https://conductscience.org/library/papers/26808323 | PubMed |
| 2 | 38156532 | Impact of Bariatric Surgery on Left Ventricular Structure and Function. | J Am Heart Assoc | 2024 | https://conductscience.org/library/papers/38156532 | PubMed |
| 3 | 27790809 | Effect of liraglutide, a glucagon-like peptide-1 analogue, on left ventricular function in stable chronic heart failure patients with and without diabetes (LIVE)-a multicentre, double-blind, randomised, placebo-controlled trial. | Eur J Heart Fail | 2017 | https://conductscience.org/library/papers/27790809 | PubMed |
| 4 | 27483064 | Effects of Liraglutide on Clinical Stability Among Patients With Advanced Heart Failure and Reduced Ejection Fraction: A Randomized Clinical Trial. | JAMA | 2016 | https://conductscience.org/library/papers/27483064 | PubMed |
| 5 | 40426935 | Navigating Sarcopenia Risks in GLP-1RA Therapy for Advanced Heart Failure. | Biomedicines | 2025 | https://conductscience.org/library/papers/40426935 | PubMed |
| 6 | 39741663 | Anti-inflammatory effects of glucagon-like peptide-1 (GLP-1) in coronary artery disease: a comprehensive review. | Front Cardiovasc Med | 2024 | https://conductscience.org/library/papers/39741663 | PubMed |
| 7 | 38587233 | Semaglutide in Patients with Obesity-Related Heart Failure and Type 2 Diabetes. | N Engl J Med | 2024 | https://conductscience.org/library/papers/38587233 | PubMed |
| 8 | 38275114 | Trends and Outcomes Associated With Bariatric Surgery and Pharmacotherapies With Weight Loss Effects Among Patients With Heart Failure and Obesity. | Circ Heart Fail | 2024 | https://conductscience.org/library/papers/38275114 | PubMed |
| 9 | 28714796 | Effect of bariatric surgery on heart failure. | Expert Rev Cardiovasc Ther | 2017 | https://conductscience.org/library/papers/28714796 | PubMed |
| 10 | 24811133 | Effects of GLP-1 on appetite and weight. | Rev Endocr Metab Disord | 2014 | https://conductscience.org/library/papers/24811133 | PubMed |
| 11 | 38732142 | Peptides Are Cardioprotective Drugs of the Future: The Receptor and Signaling Mechanisms of the Cardioprotective Effect of Glucagon-like Peptide-1 Receptor Agonists. | Int J Mol Sci | 2024 | https://conductscience.org/library/papers/38732142 | PubMed |
| 12 | 38848064 | Bariatric Metabolic Surgery vs Glucagon-Like Peptide-1 Receptor Agonists and Mortality. | JAMA Netw Open | 2024 | https://conductscience.org/library/papers/38848064 | PubMed |
| 13 | 37622663 | 2023 ESC Guidelines for the management of cardiovascular disease in patients with diabetes. | Eur Heart J | 2023 | https://conductscience.org/library/papers/37622663 | PubMed |
| 14 | 38093506 | Obesity, heart failure with preserved ejection fraction, and the role of glucagon-like peptide-1 receptor agonists. | ESC Heart Fail | 2024 | https://conductscience.org/library/papers/38093506 | PubMed |
| 15 | 39301908 | A Contemporary Review on Heart Failure with Preserved Ejection Fraction: Epidemiology, Diagnosis, and Management. | Curr Cardiol Rev | 2025 | https://conductscience.org/library/papers/39301908 | PubMed |
| 16 | 39009781 | Bariatric metabolic surgery is associated with a lower risk for heart failure versus GLP-1RAs. | Nat Med | 2024 | https://conductscience.org/library/papers/39009781 | PubMed |
| 17 | 20152253 | Structural and functional changes in left and right ventricles after major weight loss following bariatric surgery for morbid obesity. | Am J Cardiol | 2010 | https://conductscience.org/library/papers/20152253 | PubMed |
| 18 | 30623143 | The GLP-1 Analogs Liraglutide and Semaglutide Reduce Atherosclerosis in ApoE-/- and LDLr-/- Mice by a Mechanism That Includes Inflammatory Pathways. | JACC Basic Transl Sci | 2018 | https://conductscience.org/library/papers/30623143 | PubMed |
| 19 | 24980665 | Effects of the once-weekly glucagon-like peptide-1 receptor agonist dulaglutide on ambulatory blood pressure and heart rate in patients with type 2 diabetes mellitus. | Hypertension | 2014 | https://conductscience.org/library/papers/24980665 | PubMed |
| 20 | 28244632 | Safety issues with glucagon-like peptide-1 receptor agonists (pancreatitis, pancreatic cancer and cholelithiasis): Data from randomized controlled trials. | Diabetes Obes Metab | 2017 | https://conductscience.org/library/papers/28244632 | PubMed |
Cited by1
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 1 citation.
| PMID | Title | Journal | Year | In Papers |
|---|---|---|---|---|
| 42910211 | Cross-cutting circuits in heart failure with preserved ejection fraction: Integrating adipokine biology, mechanotransduction, and precision targeting. | Int J Biol Sci | 2026 | https://conductscience.org/library/papers/42910211 |
Source PubMed
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| GLP1R | 2740 | PubTator's text mining | https://conductscience.org/library/genes/2740 |
Source NCBI Gene
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/41378487
GET https://conductscience.org/api/papers/v1/41378487/references?page=2